<p>IB3-1 cells preincubated for 24 h in serum free media were additionally incubated for 24 h with increasing concentrations of the JNK inhibitor SP600125 (1, 5, 10 and 20 µM) and the mCx-I activity was measured by using BN-PAGE and spectrophotometry. A: mCx-I in-gel activity (IGA) and mCx-III (WB). B: Densitometric quantification and statistical analysis of the results shown in panel A. IGA of mCx-I was calculated as the ratio mCx-I (IGA)/mCx-III (WB). C: Spectrophotometric measurements of the mitochondrial NADH-cytochrome c reductase activity in samples obtained from the same experiments of panel A, expressed as percentage (%) relative to S9 control values. Measurements were performed in triplicate and data were expressed as mean ± SE of ...
<p>(A) Western blotting analysis of p-c-Jun, T-c-Jun and cytochrome c in SH-SY5Y cell extracts after...
<p>A) BT474 cells or B) JIMT-1 cells treated with inhibitors targeting AKT, PLC, JNK, PI3K, SRC, mTO...
<p>(A) JNK activation in response to MMC treatment (0.4 mg/ml, 5 minutes) was detected at various ti...
<p>After 24-1 cells were incubated for 24 h with increasing concentrations of the MAPK/AP-1 pathway ...
<p>After 24-1 cells were incubated for 24 h with increasing concentrations of the p38 MAPK inhibitor...
<p>S9 and IB3-1 cells preincubated for 24 h in serum free media were additionally incubated for 24 h...
<p>IB3-1 and S9 cells pre-incubated in serum free media for 24 h were incubated for additional 24 h ...
<p>A: IGA of mitochondrial extracts from Control and CFTR-stimulated IB3-1 and S9 cells (IBMX-isop-c...
The cell lines A) UM-SCC4 and B) UM-SCC47 were stimulated with 1μg/mL rituximab or 1μg/mL cetuximab ...
<p>H9c2 cells were treated with a JNK inhibitor, SP600125, followed by OGD-Rep. (A) Cell lysates wer...
<p>A: IGA of mitochondrial extracts from T84 cells after 24 h of treatment with 100 µM glibenclamide...
<p>(<b>A</b>) Exposure to 2.5 µM salinomycin induced the expression and activation of JNK, as well a...
<p>A: IGA of mitochondrial extracts from CFDE (CF cells), CFDE/6RepCFTR cells (rescued cells ectopic...
<p>WT cardiomyocytes were subjected to hypoxia/reoxygenation after 1 hr incubation with JNK inhibito...
<p>A–B: Jurkat cells (A) and CD34<sup>+</sup> HSPCs (B) were treated with TNF for 2 hours (A) or 3 h...
<p>(A) Western blotting analysis of p-c-Jun, T-c-Jun and cytochrome c in SH-SY5Y cell extracts after...
<p>A) BT474 cells or B) JIMT-1 cells treated with inhibitors targeting AKT, PLC, JNK, PI3K, SRC, mTO...
<p>(A) JNK activation in response to MMC treatment (0.4 mg/ml, 5 minutes) was detected at various ti...
<p>After 24-1 cells were incubated for 24 h with increasing concentrations of the MAPK/AP-1 pathway ...
<p>After 24-1 cells were incubated for 24 h with increasing concentrations of the p38 MAPK inhibitor...
<p>S9 and IB3-1 cells preincubated for 24 h in serum free media were additionally incubated for 24 h...
<p>IB3-1 and S9 cells pre-incubated in serum free media for 24 h were incubated for additional 24 h ...
<p>A: IGA of mitochondrial extracts from Control and CFTR-stimulated IB3-1 and S9 cells (IBMX-isop-c...
The cell lines A) UM-SCC4 and B) UM-SCC47 were stimulated with 1μg/mL rituximab or 1μg/mL cetuximab ...
<p>H9c2 cells were treated with a JNK inhibitor, SP600125, followed by OGD-Rep. (A) Cell lysates wer...
<p>A: IGA of mitochondrial extracts from T84 cells after 24 h of treatment with 100 µM glibenclamide...
<p>(<b>A</b>) Exposure to 2.5 µM salinomycin induced the expression and activation of JNK, as well a...
<p>A: IGA of mitochondrial extracts from CFDE (CF cells), CFDE/6RepCFTR cells (rescued cells ectopic...
<p>WT cardiomyocytes were subjected to hypoxia/reoxygenation after 1 hr incubation with JNK inhibito...
<p>A–B: Jurkat cells (A) and CD34<sup>+</sup> HSPCs (B) were treated with TNF for 2 hours (A) or 3 h...
<p>(A) Western blotting analysis of p-c-Jun, T-c-Jun and cytochrome c in SH-SY5Y cell extracts after...
<p>A) BT474 cells or B) JIMT-1 cells treated with inhibitors targeting AKT, PLC, JNK, PI3K, SRC, mTO...
<p>(A) JNK activation in response to MMC treatment (0.4 mg/ml, 5 minutes) was detected at various ti...